[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-344154-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-344154-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","pan-cancer-analysis-reveals-the-potential-of-plod1-as-a-prognostic-and-immune-biomarker-for-human-cancer","Pan-Cancer Analysis Reveals the Potential of PLOD1 as a Prognostic and Immune Biomarker for Human Cancer","","Pan-cancer analysis investigates PLOD1 (procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1) as both a prognostic indicator and an immune-related biomarker across human cancers. Using multiple online databases, the study evaluates pan-cancer expression, mutation, methylation, and prognostic associations, then performs correlations with immunological features. Results show aberrant PLOD1 expression in multiple tumor types, linked to poor outcomes, heterogeneous epigenetic alterations, and copy-number/methylation patterns associated with prognosis. PLOD1 also correlates with immunosuppressive microenvironment infiltration and with immune checkpoint and immunomodulatory genes, while in vitro PLOD1 knockdown reduces bladder cancer T24 cell proliferation, migration, and antiapoptotic capacity.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/pan-cancer-analysis-reveals-the-potential-of-plod1-as-a-prognostic-and-immune-biomarker-for-human-cancer/344154/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/pan-cancer-analysis-reveals-the-potential-of-plod1-as-a-prognostic-and-immune-biomarker-for-human-cancer/344154.png","ImageObject",300,407,{"name":42,"@type":43},"Clementine","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-05","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main aim of this pan-cancer study on PLOD1?","Question",{"text":63,"@type":64},"To clarify the function and potential mechanism of PLOD1 across cancers, focusing on its prognostic value and immune-related biomarker potential.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How did the study assess PLOD1 across different cancers?",{"text":68,"@type":64},"It evaluated pan-cancer expression, mutation, methylation, and prognostic value using multiple online databases, followed by correlation analyses with immunological features and functional assessments.",{"name":70,"@type":61,"acceptedAnswer":71},"What immune microenvironment relationships were observed for PLOD1?",{"text":72,"@type":64},"PLOD1 expression was positively associated with infiltration of immunosuppressive cells (such as monocytes, macrophages, and tumor-associated fibroblasts) and negatively associated with immune-killing cells including CD8+ T cells, B cells, and CD4+ T cells.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},344154,1790181596,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":117,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":103,"preview_page_count":33,"preview_urls":144},1374391974564,"https://ap-avatar.wpscdn.com/avatar/14000253aa45c000a9e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779874745381141002","Article  \nPan-Cancer Analysis Reveals the Potential of PLOD1 as a Prognostic and Immune Biomarker for Human Cancer  \nZhao Zhai, Shuo Wang, Yudong Cao, Jia Liu, Qiang Zhao, Yongpeng Ji, Xiao Yang, Xingxing Tang , Jinchao Ma and Peng Du *  \nCitation: Zhai, Z.; Wang, S.; Cao, Y.; Liu, J.; Zhao, Q.; Ji, Y.; Yang, X.; Tang, X.; Ma, J.; Du, P. Pan-Cancer Analysis Reveals the Potential of PLOD1 as a Prognostic and Immune Biomarker for Human Cancer. Biomedicines 2024, 12, 2653. [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)biomedicines12122653  \nAcademic Editors: Marie ˇCerná and Satoshi Wada  \nReceived: 14 October 2024  \nRevised: 2 November 2024  \nAccepted: 12 November 2024  \nPublished: 21 November 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \nKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Urology, Peking University Cancer Hospital & Institute, Beijing 100089, China; [zhaizhao0308@163.com](zhaizhao0308@163.com) (Z.Z.);  \n[wangshuoarea@pku.org.cn](wangshuoarea@pku.org.cn) (S.W.); [ydcao@bjmu.edu.cn](ydcao@bjmu.edu.cn) (Y.C.); [liujiabdyy@163.com](liujiabdyy@163.com) (J.L.);  \n[pkuch_zhaoq@126.com](pkuch_zhaoq@126.com) (Q.Z.); [jiyongpeng@163.com](jiyongpeng@163.com) (Y.J.); [18611979333@163.com](18611979333@163.com) (X.Y.);  \n[xingxing.tang@bjcancer.org](xingxing.tang@bjcancer.org) (X.T.); [ma15565252290@163.com](ma15565252290@163.com) (J.M.)  \n* Correspondence: [dupeng9000@126.com](dupeng9000@126.com)  \nAbstract: Background/Objectives: Procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1 (PLOD1) is known as an enhancer of collagen fiber deposition and cross-linking stability. However, there is limited information on its function in tumors. In this study, we aimed to elucidate the function and potential mechanism of action of PLOD1 across cancers. Methods: We assessed the pan-cancer expression, mutation, methylation and prognostic value of PLOD1 through multiple online databases. In addition, we performed correlation analyses of its immunological features, as well as functional assessment analyses of PLOD1 . Finally, we assessed the effect of PLOD1 knockdown on bladder tumor cells using in vitro experiments. Results: Our findings suggest that PLOD1 is aberrantly expressed in multiple cancer types, accompanied by a poor prognosis. Epigenetic alterations in PLOD1 are highly heterogeneous across a wide range of tumors, and aberrant methylation and copy number variants correlate with a poor prognosis. In the tumor microenvironment, PLOD1 expression correlated positively with the infiltration level of various immunosuppressive cells (e.g., monocytes, macrophages and tumor-associated fibroblasts) and negatively with immune-killing cells (e.g., CD8+ T cells, B cells and CD4+ T cells) . In addition, PLOD1 expression was associated with immune checkpoints and immunomodulatory genes. Finally, in vitro experiments demonstrated that knockdown of PLOD1 reduced the proliferation, migration and antiapoptotic abilities of T24 cells. Conclusions: The results of this study demonstrate that PLOD1 is a potential oncogene and prognostic biomarker in pan-cancer; tumor tissues with high PLOD1 expression reveal a relatively immunosuppressive tumor microenvironment.  \nKeywords: PLOD1; pan-cancer analysis; biomarker  \n1. Introduction  \nDespite the unremitting efforts of scientists and clinical doctors, cancer remains a major global public health problem [1] . According to the latest statistical assessments of epidemiology, the number of cancer deaths in the United States will reach 609,820 in 2023 [2] . In fact, the true outcome will be worse. This may b","cbCaig6Hchfr8WHM","https://ap.wps.com/l/cbCaig6Hchfr8WHM","pdf",15873187,"English","# Introduction\n## Pan-cancer perspective and tumor microenvironment\n## Collagen/ECM role in cancer progression\n## PLOD family and PLOD1 relevance","[{\"question\":\"What is the main aim of this pan-cancer study on PLOD1?\",\"answer\":\"To clarify the function and potential mechanism of PLOD1 across cancers, focusing on its prognostic value and immune-related biomarker potential.\"},{\"question\":\"How did the study assess PLOD1 across different cancers?\",\"answer\":\"It evaluated pan-cancer expression, mutation, methylation, and prognostic value using multiple online databases, followed by correlation analyses with immunological features and functional assessments.\"},{\"question\":\"What immune microenvironment relationships were observed for PLOD1?\",\"answer\":\"PLOD1 expression was positively associated with infiltration of immunosuppressive cells (such as monocytes, macrophages, and tumor-associated fibroblasts) and negatively associated with immune-killing cells including CD8+ T cells, B cells, and CD4+ T cells.\"}]","Pan-Cancer Analysis Reveals the Potential of PLOD1 as a Prognostic and Immune Biomarker for Human Cancer | PDF",1790053127,[145,149,153,157],{"page_no":22,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a90f7e8ecdc6e7ed92b68147f4ac806a.webp",983,1390,{"page_no":26,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f0ddf7d2668901fac60fa94d45f64f48.webp",982,1388,{"page_no":30,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9cdab040da7b41e1244f662ce2c34093.webp",981,1387,{"page_no":33,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/76e915a7bc76c752500504c5f601ebc4.webp",980,1385]